Novel combination achieves 60.8% response rate and 90.2% disease control rate in first-line non-small cell lung cancer (1L NSCLC) Notably, ~92% of all evaluable patients have PD-L1 TPS <50%, including ...

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses ...

WESTBROOK, Maine, May 15, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a provider of consumer health care and lifestyle products, is announcing its financial ...

Polpharma Group est un acteur pharmaceutique de première importance spécialisé dans les médicaments hors brevet et s’engage à améliorer la santé et la qualité de vie des patients. Son engagement en ...

Pain Relief: Red strains are known as some of the best kratom for pain, offering properties that help manage chronic discomfort. They promote a sense of physical ease, allowing you to feel more ...

MIAMI, May 15, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in two investor conferences over the coming weeks.

Chemomab Therapeutics Ltd.(Nasdaq:CMMB), (Chemomab), a clinical-stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced ...

Another gene therapy candidate, OPGx-BEST1, which Opus is developing for treatment of bestrophin-1 (BEST1)-related IRD, is on track to enter the clinic by the fourth quarter of 2025, with preliminary ...

While OTC appetite suppressant supplements like PhenQ, Capsiplex, and Phen24 work directly on hunger and fat burning, ...

By restoring balance in your gut microbiome, probiotics help you feel lighter, less gassy, and more regular. Science backs ...

With the growing popularity of probiotic supplements, the gut health market is now flooded with countless options. Among them ...

The presentation titled “ Utilization of Proteomic Testing in Pulmonary Nodule Risk Stratification at a Safety-Net Hospital: An Observational Study ” will be presented by Sonu Sahni, MD, Director of ...